Take aletinib/aletinib for bone metastasis

Alectinib/Alectinib (Alectinib) is a targeted drug mainly used to treat ALK (tyrosine kinase)-positive advanced non-small cell lung cancer (NSCLC). Although Alectinib/Alectinib has shown significant efficacy in treating ALKpositive NSCLC , it is not a standard treatment for other types of cancer or metastatic cancer. If the cancer has metastasized to the bone, where malignant cells from the lung cancer have spread to the skeletal system, alectinib may not be the most appropriate treatment option. Bone metastasis usually requires a more comprehensive treatment strategy, including radiotherapy, targeted therapy, chemotherapy, etc.